Pharmaceutical
ChemLinked
Market
Chemical
Food
Cosmetic
Pharmaceutical
Japan
Agrochemical
Sustainability
Top Searches
DMF
biological product
generic drugs
innovative drugs
clinical trial
GVP
GMP
volume-based procurement
priority review & approval
national reimbursement drug list
LOG IN
SIGN UP
LOG IN
Home
News
Insights
Database
Events
Webinars
Offline Events
Services
Home
News
Insights
Database
Laws & Regulations
Drug Catalog
ChP Standards
Events
Webinars
Offline Events
Services
Search
Insights
In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
All
Interpretation
Report
Q&A
All
Interpretation
Report
Q&A
Topic
Regulation
Guideline
Law & Regulation
Pharmacopoeia
Reference Listed Drug (RLD)
Hot topic
Bioequivalence (BE)
Clinical Trial
CMC
CRO
DMF
Drug Registration
E-commerce
GCP
GLP
GMP
GSP
License in/out
MAH
Marketing Approval
New Drug
Patent
Pharmacovigilance
Post-market
Priority Review
Real World Data
Policy
Health Insurance
NRDL
Volume-based Procurement
Product
API
Biological Product
Biosimilar
Excipient
Generic Drug
Innovative Drug
Medical Device
OTC Drug
Packaging
Pediatric Drug
Vaccine
Apply
Cancel
Biological Product
REPORT
2023 China CDE Drug Evaluation Report
Apr 24, 2024
REPORT
2022 China CDE Drug Evaluation Report
Sep 21, 2023
INTERPRETATION
[Updated] Drug Application Fees for FY 2023 in China and the U.S.
Feb 10, 2023
Q&A
China CDE Q&A | Biologics' R&D, Associated Review of APIs, Excipients, and Packaging Materials, Requirements for Changes, and More
Sep 05, 2022
REPORT
2021 China CDE Drug Evaluation Report
Jul 04, 2022
REPORT
China Drug Evaluation Report 2020-Critical Numbers
Aug 27, 2021
REPORT
Selection of 2019 China Center for Drug Evaluation Annual Report
Mar 08, 2021
Name
*
Company
*
Email
*
Message
*
Cancel
Get in Touch Now